Site icon Medical Market Report

Cetirizine Hydrochloride Market To Develop Speedily With CAGR Of 3.2% By 2032

Market Overview

As a language model, I do not have access to the most up-to-date market data, but I can give you an overview of cetirizine hydrochloride’s market based on available information up until my knowledge cutoff date of 2022.

Cetirizine hydrochloride is an antihistamine medication prescribed to relieve allergy-related symptoms such as itching, sneezing, and a runny nose. It’s often sold under brand names such as Zyrtec, Cetzine, or Reactine.

The global cetirizine hydrochloride market size was valued at USD 1287.6 million in 2022 and is expected to exhibit a robust CAGR of 3.2%

The Cetirizine hydrochloride market is being driven by an increasing prevalence of allergies and demand for effective allergy medications. Air pollution levels, changing climate patterns, and increased use of chemical substances in food products have all played a role in contributing to this rise in allergic cases.

Cetirizine hydrochloride is highly competitive on the market, with many manufacturers offering generic versions of the drug. Furthermore, Zyrtec – currently the most popular brand – has had its patent expire, making it easier for competitors to enter this space.

The distribution of cetirizine hydrochloride is generally available over the counter (OTC) in many countries, making it accessible to consumers. However, those with more severe allergies can access prescription-strength versions of the drug as well.

Key Takeaways

To get a detailed analysis of other segments, Request For Sample Report:


Key Market Segments



Key Market Players




Recent Developments

Contact our Market Specialist Team

Global Business Development Teams – (Powered By Prudour Pvt. Ltd.)

Send Email:

Address: 420 Lexington Avenue, Suite 300, New York City, NY 10170, United States

Tel: +1 718 618 4351

Exit mobile version